Brenntag Pharma and Indovinya Form Exclusive European Distribution Partnership for Oxipurity® Polyethylene Glycols and Polysorbates Across Eight Markets

Brenntag Pharma and Indovinya Form Exclusive European Distribution Partnership for Oxipurity® Polyethylene Glycols and Polysorbates Across Eight Markets

(IN BRIEF) Brenntag Pharma has entered into an exclusive distribution partnership with Indovinya Belgium N.V., part of the Indorama Group, for Oxipurity® polyethylene glycols and polysorbates used in pharmaceutical and nutraceutical applications across France, Italy, Belgium, the Netherlands, Denmark, Finland, Sweden and Norway. The agreement expands Brenntag’s pharmaceutical excipient portfolio and combines its European distribution network and technical support capabilities with Indovinya’s manufacturing expertise in non-ionic surfactants. Indovinya’s Oxipurity® 4000 PEG range is manufactured under EXCiPACT GMP certification and complies with EP and USP requirements, while Oxipurity® 7080 polysorbates are produced according to ANVISA and IPEC-PQG GMP guidelines and also meet EP and USP standards. The products are used across dosage forms including tablets, capsules, oral liquids, topical preparations and suppositories. Brenntag and Indovinya said the partnership will support formulation development, regulatory confidence and reliable ingredient supply while strengthening their positions in Europe’s pharmaceutical excipient and nutraceutical markets.

(PRESS RELEASE) ESSEN, 9-Sep-2026 — /EuropaWire/ — Brenntag Pharma has entered into a new exclusive distribution partnership with Indovinya Belgium N.V., part of the Indorama Group, covering selected polyethylene glycols and polysorbates for pharmaceutical and nutraceutical applications across eight European countries.

Under the agreement, Brenntag will distribute Indovinya’s Oxipurity® polyethylene glycol and polysorbate portfolio in France, Italy, Belgium, the Netherlands, Denmark, Finland, Sweden and Norway, expanding its range of pharmaceutical excipients and strengthening its position in formulation markets across Europe.

The partnership combines Indovinya’s manufacturing expertise in non-ionic surfactants with Brenntag’s regional distribution network, technical support capabilities and customer relationships.

Agreement expands Brenntag’s pharmaceutical excipient portfolio

Brenntag said the partnership strengthens its offering of high-quality excipients used across pharmaceutical and nutraceutical formulation.

Polyethylene glycols, also known as Macrogols, and polysorbates are multifunctional excipients used in a wide range of dosage forms, including tablets, hard and soft capsules, oral liquid formulations, topical preparations and suppositories.

The agreement gives Brenntag customers across the covered European markets access to Indovinya’s Oxipurity® range together with regional commercial and technical support.

Oxipurity® products manufactured to pharmaceutical quality standards

Indovinya’s Oxipurity® 4000 polyethylene glycol product line is manufactured under EXCiPACT GMP certification and complies with the requirements of the European Pharmacopoeia (EP) and United States Pharmacopeia (USP).

The Oxipurity® 7080 polysorbate range is produced in accordance with ANVISA and IPEC-PQG Good Manufacturing Practices guidelines and also complies with EP and USP pharmacopoeial standards.

Brenntag said these quality and regulatory frameworks are intended to provide European pharmaceutical and nutraceutical customers with a reliable source of compliant excipients for formulation development and commercial manufacturing.

Partnership covers eight European markets

The exclusive distribution arrangement includes:

France
Italy
Belgium
Netherlands
Denmark
Finland
Sweden
Norway

The geographic scope gives Brenntag an opportunity to expand the Oxipurity® portfolio across established pharmaceutical markets while providing customers with closer access to product expertise and supply-chain support.

Brenntag targets new pharmaceutical and nutraceutical formulation projects

Joakim Rehné, Regional President EMEA at Brenntag Pharma, said the partnership expands Brenntag’s high-quality excipient offering and supports its strategy of bringing reliable, compliant and technically supported ingredients closer to customers.

He highlighted the combination of Indovinya’s EXCiPACT-certified manufacturing capabilities and regulatory foundation with Brenntag’s regional presence and customer proximity.

According to Rehné, the partnership positions the companies to support formulation development across Europe while generating additional opportunities in the excipient and nutraceutical markets.

Indovinya strengthens European pharmaceutical presence

Fabiana Citraro Marra, Global Director Marketing & Innovation at Indovinya, described the agreement as an important milestone in the company’s strategy to strengthen its position in European pharmaceutical and nutraceutical markets.

She said combining Brenntag’s distribution capabilities and customer reach with Indovinya’s Oxipurity® excipient portfolio will allow the companies to provide formulators with consistent product quality, greater regulatory confidence and reliable access to essential ingredients.

Partnership combines manufacturing expertise with regional distribution

Indovinya is a producer of non-ionic surfactants and contributes manufacturing and quality-management expertise to the partnership, while Brenntag provides an established distribution infrastructure across the relevant European markets.

The companies expect this combination to support customers throughout formulation and product-development activities while improving access to pharmaceutical-grade polyethylene glycols and polysorbates.

The agreement also reinforces Brenntag Pharma’s broader strategy of developing its specialist pharmaceutical ingredients portfolio through partnerships with established manufacturers.

About Indovinya:

Indovinya is the global specialty chemical and surfactants division of Indorama Ventures. It ranks as the top producer of nonionic surfactants and ethylene oxide in the Americas and the second-largest ethoxylation company globally, operating 15 manufacturing sites with roughly 3,000 employees. Indovinya Belgium N.V. is part of the Indorama Group, a global leader in surfactants and specialty ingredients. The company offers a broad portfolio of high‑purity polyethylene glycols and polysorbates for regulated markets, supported by GMP‑certified production and strong quality systems. For more please visit: https://indovinya.indoramaventures.com

Brenntag is the global market leader in chemicals and ingredients distribution. The company holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, Brenntag has more than 17,300 employees worldwide and operates a network of around 600 sites in more than 70 countries. In 2025, Brenntag generated sales of 15.2 billion EUR. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its own sector and the industries served. Brenntag shares have been listed at the Frankfurt Stock Exchange since 2010, in the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 30 ESG and DAX ESG Target. For more information, visit www.brenntag.com.

Media Contact:

Helmut Weintögl
Brenntag SE
Communications EMEA
Telephone: +49 (201) 6496-1339
E-Mail: global.communications@brenntag.com
www.brenntag.com

SOURCE: Brenntag SE